Biological, pharmaceutical, and analytical considerations with respect to the transport media used in the absorption screening system, Caco-2
- PMID: 12884242
- DOI: 10.1002/jps.10408
Biological, pharmaceutical, and analytical considerations with respect to the transport media used in the absorption screening system, Caco-2
Abstract
During the evaluation and selection of drug candidates, the Caco-2 cell culture system is commonly used for the determination of intestinal transport characteristics and to anticipate permeability limited drug absorption. Although classic HBSS-like buffered salt solutions are commonly used to perform Caco-2 transport experiments, different shortcomings (e.g., adsorption and low solubility) have been associated with the use of plain aqueous buffers. As transport experiments performed with unoptimized conditions may compromize the value of the Caco-2 model as a permeation screening tool, many efforts have been made to optimize the experimental conditions of Caco-2 transport assays. In this minireview, the hurdles associated with the use of saline aqueous buffers in Caco-2 transport experiments are summarized and the different options, which have been proposed to overcome these issues, are reviewed and discussed. Biologically, pharmaceutically, as well as analytically relevant media affecting the outcome of the transport experiments are described. Unfortunately, up to now, no systematic studies comparing the different experimental conditions have been performed, jeopardizing the possibility to define a (single) optimal solution to overcome the different issues associated with the use of saline aqueous buffers. Based on the reported options it can be proposed to use DMSO (<or=1%) in standard screening procedures for the ranking of compounds based on their apical to basolateral transport. If compounds are not soluble in DMSO 1%, dimethylacetamide (3%) or N-1-methyl-pyrrolidone (2.5%) are good alternatives. However, these options do not imitate the in vivo situation. If one wants to take into account the physiological relevance of the media, the use of a biologically relevant apical medium (e.g., FASSIF) in combination with an analytically friendly, sink condition creating basolateral solvent (e.g., containing a micelle forming agent) can be suggested.
Copyright 2003 Wiley-Liss, Inc.
Similar articles
-
Current industrial practices of assessing permeability and P-glycoprotein interaction.AAPS J. 2006 Jan 13;8(1):E1-13. doi: 10.1208/aapsj080101. AAPS J. 2006. PMID: 16584115 Free PMC article. Review.
-
Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.Int J Pharm. 2004 Apr 15;274(1-2):221-32. doi: 10.1016/j.ijpharm.2004.01.014. Int J Pharm. 2004. PMID: 15072798
-
Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs.Int J Pharm. 2008 Aug 6;360(1-2):148-55. doi: 10.1016/j.ijpharm.2008.04.034. Epub 2008 Apr 29. Int J Pharm. 2008. PMID: 18539418
-
Biorelevant media for transport experiments in the Caco-2 model to evaluate drug absorption in the fasted and the fed state and their usefulness.Eur J Pharm Biopharm. 2014 Apr;86(3):438-48. doi: 10.1016/j.ejpb.2013.10.017. Epub 2013 Oct 31. Eur J Pharm Biopharm. 2014. PMID: 24184673
-
Variability in Caco-2 and MDCK cell-based intestinal permeability assays.J Pharm Sci. 2008 Feb;97(2):712-25. doi: 10.1002/jps.21010. J Pharm Sci. 2008. PMID: 17542022 Review.
Cited by
-
Challenges in Permeability Assessment for Oral Drug Product Development.Pharmaceutics. 2023 Sep 28;15(10):2397. doi: 10.3390/pharmaceutics15102397. Pharmaceutics. 2023. PMID: 37896157 Free PMC article. Review.
-
Current industrial practices of assessing permeability and P-glycoprotein interaction.AAPS J. 2006 Jan 13;8(1):E1-13. doi: 10.1208/aapsj080101. AAPS J. 2006. PMID: 16584115 Free PMC article. Review.
-
Using Human Plasma as an Assay Medium in Caco-2 Studies Improves Mass Balance for Lipophilic Compounds.Pharm Res. 2018 Sep 17;35(11):210. doi: 10.1007/s11095-018-2493-3. Pharm Res. 2018. PMID: 30225649 Free PMC article.
-
Shape effect in the design of nanowire-coated microparticles as transepithelial drug delivery devices.ACS Nano. 2012 Sep 25;6(9):7832-41. doi: 10.1021/nn3019865. Epub 2012 Aug 24. ACS Nano. 2012. PMID: 22900471 Free PMC article.
-
Phorbol 12-myristate 13-acetate inhibits P-glycoprotein-mediated efflux of digoxin in MDCKII-MDR1 and Caco-2 cell monolayer models.Acta Pharmacol Sin. 2014 Feb;35(2):283-91. doi: 10.1038/aps.2013.157. Epub 2013 Dec 23. Acta Pharmacol Sin. 2014. PMID: 24362330 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials